PHC GROUPPHC Holdings Corporation

  • About Us
  • Group Companies
  • Products & Services
  • Sustainability
  • Investor Relations
  • Newsroom

About Us

About PHC GroupCEO MessageMission, Vision & ValuesValue Creation PlanHistory LeadershipPHC Group by the Numbers

Group Companies

Ascensia LSI Medience Wemex Mediford Epredia PHCbi PHC IVD

Products & Services

Cancer Pathology Biologic & Cell Preservation Diagnostic Testing Patient Record & Billing Software Diabetes Management Medical Device & Drug Delivery

Sustainability

Sustainability
  • CEO Message
  • Materiality
  • Sustainability Management
  • PHC GROUP Integrated Report
  • Stakeholder Engagement
  • Environment image
    Environment
  • Society image
    Social
  • Governance image
    Governance

Investor Relations

INVESTOR RELATIONS

MANAGEMENT

  • Corporate Governance
  • IR Basic Policy
  • Business Risks

IR LIBRARY

  • Financial Results
  • Presentation Materials
  • IR Materials
  • Historical Financial Data
  • PHC GROUP Integrated Report
  • Mid-term Plan
  • Our Group Introduction

STOCK INFORMATION

  • Stock Overview
  • General Meeting of Shareholders
  • Shareholder Newsletter
  • Stock Quotations
  • Analyst Coverage
IR News Financial Highlights IR Calendar Contact IR Disclaimer

Newsroom

NEWSROOM

NEWS

  • PHC Holdings Corporation
  • PHC Group Companies
CareersContact
JP

Other PHC Group Websites

  • Ascensia Diabetes Care Holdings AG
  • PHC Corporation
  • LSI Medience Corporation
  • Wemex Corporation
  • Mediford Corporation
  • Epredia Holdings Ltd.
  • PT PHC Indonesia
  • PHC Corporation of North America
  • PHC Europe B.V.
  • SciMed (ASIA) Pte Ltd
  • Amelieff Corporation

Other PHC Group Websites

  • Ascensia Diabetes Care Holdings AG
  • PHC Corporation
  • LSI Medience Corporation
  • Wemex Corporation
  • Mediford Corporation
  • Epredia Holdings Ltd.
  • PT PHC Indonesia
  • PHC Corporation of North America
  • PHC Europe B.V.
  • SciMed (ASIA) Pte Ltd
  • Amelieff Corporation
CareersContactJP
About Us > CEO Message

Corporate


Message from PHC Group President,
Representative Director, and CEO Kyoko Deguchi

For over 50 years, PHC Group has been providing innovative precision and digital health solutions that advance the research, diagnosis, treatment, and prevention of disease.

Every day, in more than 125 countries and regions around the world, PHC Group companies are sharing ideas and resources across our interconnected businesses. As “One PHC,” our trusted brands are working to bring quality and innovation at every step in the healthcare journey.

  • In our Diabetes Management Domain, Ascensia Diabetes Care provides cutting-edge glucose monitoring technology to simplify the way people with diabetes manage their health. Our blood glucose monitoring products are used by an estimated 10 million people worldwide. As the market shifts to continuous glucose monitoring, we have partnered with Senseonics to deliver the world’s first longterm implantable CGM, offering flexibility and peace of mind for people with diabetes.
  • In our Healthcare Solutions Domain, Wemex has Japan’s largest market share for medical-receipt computers and electronic medical record systems in clinics and pharmacies. We will continue to drive digital transformation in medical care through telemedicine and medical data innovation. LSI Medience provides services in clinical testing through analysis, including cancer diagnostics, genetic testing, and sports doping testing, while Mediford supports a wide range of research and drug development, from basic development to clinical trials.
  • In our Diagnostics & Life Sciences Domain, we contribute to the early detection and treatment of disease. Epredia offers precision cancer diagnostic solutions including digital technologies to improve the laboratory workflow and support more efficient and accurate decisions. PHCbi award-winning ultra-low temperature freezers support research laboratories with industry-leading energy-saving performance. Our PHC IVD contributes to real-time diagnostics through highly accurate and compact POCT (point of care testing) device.

In 2024, we adopted a new vision: Be a leader in precision technology that powers the future of healthcare. We drive innovation by utilizing our group’s extensive touchpoints in the healthcare field and fostering synergy through internal collaboration.

On behalf of PHC Group, thank you for your interest in our companies. We are proud to be your partner in delivering precision technology for the future of health.

Kyoko Deguchi
President, Representative Director and CEO
PHC Holdings Corporation

Terms of UsePrivacy PolicyFacebookLinkedIn © PHC Holdings Corporation All rights reserved.